NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,344,087 | +5.8% | 23,013 | +4.8% | 0.12% | +4.3% |
| Q2 2023 | $2,215,512 | +17.7% | 21,955 | +7.3% | 0.12% | +1.8% |
| Q1 2023 | $1,881,798 | -14.3% | 20,454 | -15.4% | 0.11% | -14.3% |
| Q4 2022 | $2,194,552 | +22.8% | 24,190 | +2.9% | 0.13% | +8.1% |
| Q3 2022 | $1,787,000 | -21.5% | 23,512 | -12.8% | 0.12% | +9.8% |
| Q2 2022 | $2,275,000 | -2.6% | 26,977 | +1.4% | 0.11% | +12.0% |
| Q1 2022 | $2,335,000 | +4.5% | 26,611 | +4.2% | 0.10% | +17.6% |
| Q4 2021 | $2,234,000 | +5.9% | 25,541 | -0.8% | 0.08% | +4.9% |
| Q3 2021 | $2,110,000 | -9.0% | 25,752 | +2.2% | 0.08% | -10.0% |
| Q2 2021 | $2,318,000 | +7.8% | 25,202 | -0.1% | 0.09% | +50.0% |
| Q1 2021 | $2,150,000 | -1.6% | 25,231 | -5.0% | 0.06% | -31.8% |
| Q4 2020 | $2,184,000 | -10.0% | 26,572 | -4.5% | 0.09% | -30.2% |
| Q3 2020 | $2,426,000 | +5.2% | 27,814 | +5.1% | 0.13% | -1.6% |
| Q2 2020 | $2,305,000 | +27.1% | 26,468 | +15.9% | 0.13% | +4.9% |
| Q1 2020 | $1,813,000 | -18.5% | 22,830 | -2.2% | 0.12% | +2.5% |
| Q4 2019 | $2,225,000 | +14.6% | 23,332 | +5.0% | 0.12% | +2.6% |
| Q3 2019 | $1,942,000 | +7.5% | 22,222 | +12.9% | 0.12% | +3.6% |
| Q2 2019 | $1,807,000 | +10.6% | 19,680 | +15.7% | 0.11% | +3.7% |
| Q1 2019 | $1,634,000 | +46.9% | 17,003 | +31.3% | 0.11% | +31.7% |
| Q4 2018 | $1,112,000 | +22.2% | 12,947 | +22.5% | 0.08% | +34.4% |
| Q3 2018 | $910,000 | +14.5% | 10,566 | +0.3% | 0.06% | -1.6% |
| Q2 2018 | $795,000 | -3.2% | 10,536 | +3.7% | 0.06% | -13.9% |
| Q1 2018 | $821,000 | -2.7% | 10,159 | +1.0% | 0.07% | -4.0% |
| Q4 2017 | $844,000 | -15.4% | 10,061 | -13.5% | 0.08% | -24.2% |
| Q3 2017 | $998,000 | +40.8% | 11,633 | +36.9% | 0.10% | +35.6% |
| Q2 2017 | $709,000 | +27.1% | 8,499 | +13.1% | 0.07% | +25.9% |
| Q1 2017 | $558,000 | +4.1% | 7,513 | +2.0% | 0.06% | -18.3% |
| Q4 2016 | $536,000 | -5.1% | 7,366 | +2.9% | 0.07% | -6.6% |
| Q3 2016 | $565,000 | -4.4% | 7,155 | 0.0% | 0.08% | -11.6% |
| Q2 2016 | $591,000 | +17.7% | 7,155 | +1.7% | 0.09% | +11.7% |
| Q1 2016 | $502,000 | – | 7,033 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |